Publications by authors named "Thomas D Harris"

Claim this Profile
N
Nucleophilic Amination of Aryl Halides with an Azanide Surrogate.
Bradley D Cooper, Thomas D Harris, Ethan R X Lim, Katherine A Hooper, George F S Whitehead

Chemistry· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and Cardiac Imaging of (18)F-Ligands Selective for β1-Adrenoreceptors.
Heike S Radeke, Ajay Purohit, Thomas D Harris, Kelley Hanson, Reinaldo Jones

ACS Med Chem Lett· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiolabeled divalent peptidomimetic vitronectin receptor antagonists as potential tumor radiotherapeutic and imaging agents.
Thomas D Harris, Edward Cheesman, Anthony R Harris, Richard Sachleben, D Scott Edwards

Bioconjug Chem· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationships of 111In- and 99mTc-labeled quinolin-4-one peptidomimetics as ligands for the vitronectin receptor: potential tumor imaging agents.
Thomas D Harris, Shirley Kalogeropoulos, Tiffany Nguyen, Gregory Dwyer, D Scott Edwards

Bioconjug Chem· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis.
Patrick M Winter, Anne M Neubauer, Shelton D Caruthers, Thomas D Harris, J David Robertson

Arterioscler Thromb Vasc Biol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MR three-dimensional molecular imaging of intramural biomarkers with targeted nanoparticles.
Tillmann Cyrus, Dana R Abendschein, Shelton D Caruthers, Thomas D Harris, Veronica Glattauer

J Cardiovasc Magn Reson· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alphavbeta3-targeted detection of arteriopathy in transplanted human coronary arteries: an autoradiographic study.
Jiasheng Zhang, Svetlana Krassilnikova, Amir A Gharaei, Hooman Rastegar Fassaei, Leila Esmailzadeh, Thomas D Harris

FASEB J· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of leukotriene B4 antagonists labeled with In-111 or Tc-99m to image infectious and inflammatory foci.
Matthias Broekema, Julliëtte J E M van Eerd, Wim J G Oyen, Frans H M Corstens, Rob M J Liskamp, Thomas D Harris

J Med Chem· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging of infection and inflammation with an improved 99mTc-labeled LTB4 antagonist.
Julliëtte E M van Eerd, Matthias Broekema, Thomas D Harris, D Scott Edwards, Wim J G Oyen

J Nucl Med· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scintigraphic imaging of infectious foci with an 111In-LTB4 antagonist is based on in vivo labeling of granulocytes.
Julliëtte E M van Eerd, Wim J G Oyen, Thomas D Harris, Huub J J M Rennen, D Scott Edwards

J Nucl Med· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular MR imaging of melanoma angiogenesis with alphanubeta3-targeted paramagnetic nanoparticles.
Anne H Schmieder, Patrick M Winter, Shelton D Caruthers, Thomas D Harris, Todd A Williams

Magn Reson Med· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
9
90Y and 111In complexes of a DOTA-conjugated integrin alpha v beta 3 receptor antagonist: different but biologically equivalent.
David C Onthank, Shuang Liu, Paula J Silva, John A Barrett, Thomas D Harris

Bioconjug Chem· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scintigraphic detection of pulmonary aspergillosis in rabbits with a radiolabeled leukotriene b4 antagonist.
Julliëtte E M van Eerd, Huub J J M Rennen, Wim J G Oyen, Thomas D Harris, D Scott Edwards

J Nucl Med· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of injury-induced vascular remodeling by targeting activated alphavbeta3 integrin in vivo.
Mehran M Sadeghi, Svetlana Krassilnikova, Jiasheng Zhang, Amir A Gharaei, Hooman Rastegar Fassaei, Thomas D Harris

Circulation· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction.
David F Meoli, Mehran M Sadeghi, Svetlana Krassilnikova, Brian N Bourke, Frank J Giordano, Thomas D Harris

J Clin Invest· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anaerobic 90Y- and 177Lu-labeling of a DOTA-conjugated nonpeptide vitronectin receptor antagonist.
Shuang Liu, Thomas D Harris, Charles E Ellars, D Scott Edwards

Bioconjug Chem· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging of experimental colitis with a radiolabeled leukotriene B4 antagonist.
Julliëtte E M van Eerd, Peter Laverman, Wim J G Oyen, Thomas D Harris, D Scott Edwards

J Nucl Med· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging.
Patrick M Winter, Shelton D Caruthers, Andrea Kassner, Thomas D Harris, Lori K Chinen

Cancer Res· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and evaluation of radiolabeled integrin alpha v beta 3 receptor antagonists for tumor imaging and radiotherapy.
Thomas D Harris, Shirley Kalogeropoulos, Tiffany Nguyen, Shuang Liu, Judit Bartis

Cancer Biother Radiopharm· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A bivalent leukotriene B(4) antagonist for scintigraphic imaging of infectious foci.
Julliëtte E M van Eerd, Wim J G Oyen, Thomas D Harris, Huub J J M Rennen, D Scott Edwards

J Nucl Med· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of myocardial inflammation produced by experimental coronary occlusion and reperfusion with 99mTc-RP517, a new leukotriene B4 receptor antagonist that preferentially labels neutrophils in vivo.
Laurent M Riou, Mirta Ruiz, Gail W Sullivan, Joel Linden, Howard Leong-Poi, Thomas D Harris

Circulation· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis